Hamburg, March 31, 2020 In 2020, Eppendorf AG, the Hamburg life science company is presenting its highly prestigi...
South Korea based OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced that the Company h...
Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate from constructs it has been worki...
Sanofi Pasteur, the vaccines global business unit of Sanofi, and US based Translate Bio, a clinical-stage messenger RNA ...
Pharma major Lupin Limited (Lupin) on 30 March 2020 announced the receipt of the Establishment Inspection Report (EIR) f...
Japan based Daiichi Sankyo Company, Limited and Kitasato Pharmaceutical Industry Co., Ltd. have announced the terminatio...
US based CG Oncology, Inc. has announced an exclusive license, development and commercialization agreement with Japanese...
South Korea based Bio-Pharm Solutions Co., Ltd. has expanded its clinical pipelines from infantile spasms (IS) to status...
South Korea based OliX Pharmaceuticals, Inc., a leading developer of RNA interference (RNAi), has announced that it...
Japan based Daiichi Sankyo Company, Limited has announced the approval of ENHERTU® (trastuzumab deruxtecan), a HER2 ...
Azelis, a leading distributor of speciality chemicals and food ingredients, announces its new distribution agreement wit...
For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug products, Ther...
Since the outbreak of COVID-19, people around the globe have been eagerly awaiting a real breakthrough on its treatment....
SUDA Pharmaceuticals Ltd, a leader in oro-mucosal drug delivery based in Australia, has announced that it has entered in...
On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the p...
Congratulations on your new role. What are the main agendas behind the recently announced dual leadership at Eppendorf? ...
Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centri...
Japan based RIBOMIC Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics has signed the li...
Enzychem Lifesciences, Corp., a global biopharmaceutical company headquartered in Seoul, Korea, is advancing a...
The CPhI Pharma portfolio confirms new exhibition dates for CPhI Japan, CPhI South East Asia and CPhI North Am...
German firm BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd have announced a strategic dev...
AbCellera and Eli Lilly and Company have announced that they have entered into an agreement to co-develop antibody (Ab) ...
US based Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing and delivering treatments that ...
India based Zydus Cadila, an innovation-driven global pharmaceutical company, and US based XOMA Corporation have announc...
Canada based Correvio Pharma, a specialty pharmaceutical company focused on commercializing hospital drugs, and Hong Kon...
